SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-291053
Filing Date
2020-11-12
Accepted
2020-11-12 07:36:59
Documents
3
Period of Report
2020-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d64379d8k.htm 8-K 17054
2 EX-99.1 d64379dex991.htm EX-99.1 76361
3 GRAPHIC g64379g1112015345248.jpg GRAPHIC 3321
  Complete submission text file 0001193125-20-291053.txt   99259
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 201303394
SIC: 2836 Biological Products, (No Diagnostic Substances)